Motivation: Low-rank matrix completion has been demonstrated to be powerful in predicting antigenic distances among influenza viruses and vaccines from partially revealed hemagglutination inhibition table. Meanwhile, influenza hemagglutinin (HA) protein sequences are also effective in inferring antigenic distances. Thus, it is natural to integrate HA protein sequence information into low-rank matrix completion model to help infer influenza antigenicity, which is critical to influenza vaccine development. Results: We have proposed a novel algorithm called biological matrix completion with side information (BMCSI), which first measures HA protein sequence similarities among influenza viruses (especially on epitopes) and then integrates the similarity information into a low-rank matrix completion model to predict influenza antigenicity. This algorithm exploits both the correlations among viruses and vaccines in serological tests and the power of HA sequence in predicting influenza antigenicity. We applied this model into H3N2 seasonal influenza virus data. Comparing to previous methods, we significantly reduced the prediction root-mean-square error in a 10-fold cross validation analysis. Based on the cartographies constructed from imputed data, we showed that the antigenic evolution of H3N2 seasonal influenza is generally S-shaped while the genetic evolution is half-circle shaped. We also showed that the Spearman correlation between genetic and antigenic distances (among antigenic clusters) is 0.83, demonstrating a globally high correspondence and some local discrepancies between influenza genetic and antigenic evolution. Finally, we showed that 4.4%61.2% genetic variance (corresponding to 3.11 6 1.08 antigenic distances) caused an antigenic drift event for H3N2 influenza viruses historically. Availability and implementation: The software and data for this study are available at http://bi.sky. zstu.edu.cn/BMCSI/.
Introduction
Each year, seasonal influenza kills an estimated 250 000-500 000 people worldwide, putting a big threat to human health and world economy (http://www.who.int/mediacentre/factsheets/fs211/en/). The primary option to prevent influenza infection is vaccination (Smith et al., 2004) , whose effectiveness depends largely on the antigenic similarity between the epidemic influenza viruses and vaccine strains (i.e. the strains the vaccine is designed to protect against). However, influenza viruses mutate rapidly especially on the two surface proteins hemagglutinin (HA) and neuraminidase (NA) to escape from population immunity (Stohr, 2002) . Thus, a timely identification of the effectiveness of known vaccines against fast evolving influenza viruses is crucial to vaccine updating and influenza surveillance (Cai et al., 2010; Sun et al., 2013) .
One of the most popular experimental methods to characterize antigenically influenza viruses is the hemagglutination inhibition (HI) assay (Hirst, 1943) , a binding assay to evaluate the ability of antisera to block HA from agglutinating red blood cells (RBC). The concept of antigenic distance is also proposed to quantify the antigenic closeness among antigens based on immunological assays such as HI assay. The antigenic distance according to one reference antiserum is clear. For example, if one testing antigen has a titre of 640 for the reference antiserum and another testing antigen has a titre of 40, then it could be approximately 4 units, which is log 2 640=40 ð Þ . There are several ways to define the antigenic distance according to multiple reference antiserum. For example, it is defined to be the Euclidean distance between their representing vectors in a normalized HI table in Cai et al. (2010) .
HI titers of influenza antigens (viruses) against multiple antisera (vaccines) and their derived antigenic distances provide a good resource for comparing the antigenic similarity of influenza viruses (Fouchier and Smith, 2010; Neher et al., 2016; Smith et al., 2004) . However, HI assay faces a multitude of challenges including high cost and long time in sera generation, just to name a few. Thus, accurate computational methods to estimate the antigenicity of influenza viruses are highly demanding for prioritizing important viruses for further experimental studies (Sun et al., 2013) .
There are a number of computational tools to predict and visualize the antigenicity of influenza viruses including imputation-based methods and sequence-based methods. The imputation-based methods usually assume that the antigen and antiserum spaces are of low dimensions (comparing to the numbers of antigens and antisera), which could be fully recovered from partially revealed HI titers (Lapedes and Farber, 2001 ). For example, Smith et al. introduced antigenic maps, in which antigens and antisera are represented by vertices in a 2D Euclidean space (Smith et al., 2004) . They first transformed known HI titers between antigens and antisera into distances, and then applied a modified multidimensional scaling (MDS) method to embed the antigens and antisera into a 2D map. By fixing the positions of antigens and antisera, they implicitly imputed the distances between antigen and antiserum with unknown HI titer. Alternatively, Cai et al. first explicitly imputed a normalized HI table (consisting of both known HI titers and unknown ones called missing values) through a low-rank matrix completion method. They then mapped the antigens into a 2D (Cai et al., 2010) or 3D (Barnett et al., 2012) antigenic map based on antigenic distances calculated from the fully imputed table. Both methods are good in revealing global antigenic evolution of H3N2 influenza viruses, however, they also suffer a few limitations. For example, a 10-fold cross validation study showed that the root-mean-square error (RMSE) between imputed antigenic distances and true distances is 1.05 for Cai et al. and 1.04 for Smith et al (Cai et al., 2010) . The error should be further reduced since 1 unit in antigenic distance corresponds to 2 fold change in HI titer (Smith et al., 2004) . In addition, Cai et al. forced the antigens to evolve alongside a straight line by their temporal model to avoid circular shape of antigenic evolution. However, it might be better to infer antigenic evolution based purely on the data (Cai et al., 2010) .
Different from imputation-based methods, sequence-based antigenic prediction methods exploit the intimate correlation between influenza antigenicity and HA protein. By using mutations in HA1 (a sub-unit of HA forming globular domain) sequence across influenza viruses as predictors and their antigenic distances as responses, these methods are capable of inferring antigenically important mutations or co-mutations in HA1 sequences, based on which to develop antigenic prediction models (Liao et al., 2008; Sun et al., 2013; Yang et al., 2014 (Liao et al., 2008) . Huang et al. predicted antigenic variants using a decision tree algorithm (Huang et al., 2009) . However, these methods depend largely on the reliability of the selected antigenicity-associated sites, which are known to change rapidly (Kaverin et al., 2002; Sun et al., 2013) .
In this paper, we propose a novel method called biological matrix completion with side information (BMCSI) to predict influenza antigenicity by integrating HA1 protein sequence similarity into matrix completion model. We apply this model into the H3N2 seasonal influenza data from 1968 to 2003. More specifically, we construct antigenic cartographies based on the predicted values, evaluate historical vaccine strains, and study the relationship between genetic and antigenic evolution of H3N2 influenza viruses.
Materials and methods

Problem formulation
An HI table can be represented as a matrix of m rows (antigens) and n columns (antisera). There are three types of entries in a HI table, namely regular HI titers (Type I data), low reactors (Type II data, i.e. the titers less than a threshold) and missing values (Type III data) (Cai et al., 2010) . The HI table was normalized as described in (Cai et al., 2010; Smith et al., 2004; Sun et al., 2013) , and let M ¼ M ij Â Ã mÂn be the normalized matrix. Since sequencing is very cheap and fast, we assume that the HA1 protein sequence of all viruses are available. The problem is how to accurately impute the missing entries and evaluate Type II entries based on revealed Type I entries and HA sequence information.
A low-rank matrix completion model with side information
Let X be the underlying matrix (that X) to recover and r be its rank. Lapedes and Farber observed thatX is on a low dimensional spaces for influenza viruses (Lapedes and Farber, 2001 ) and thus we assume r ( min m; n ð Þ. Let E be the index set of M corresponding to Type I and Type II data and M E X E À Á denote the restricted matrix of M X ð Þ on E. Two optimization models had been proposed in Cai et al. (2010) and also our previous software (Barnett et al., 2012) to estimate X with and without Type II data.
Model 1 Without Type II data (Cai et al., 2010) 
2 À 1 when z ! 1 and g z ð Þ ¼ 0, otherwise. U i and V i denote the i th row of U and V respectively, and a ¼ max m; n ð Þ (Cai et al., 2010; Keshavan et al., 2010) .
Model 2 With Type II data (Cai et al., 2010) . Let h ij be the threshold values of Type II data andh ij ¼ À1 if the corresponding entry is not a Type II data.
and IðX E ij ! h ij Þ ¼ 0 otherwise. Though proven to be effective in constructing antigenic cartography, the above model has a 10-fold cross-validation RMSE of 1.04 on H3N2 human influenza data from 1968 to 2003 (Smith et al., 2004) and it is infeasible if a whole row or column in M is missing (Barnett et al., 2012; Cai et al., 2010) . In addition, Cai et al. also found that the geometric shape of the evolution usually could not be recovered accurately in this model without the short-term straight line assumption, which might be caused by the fact that HI data is not missing randomly (Cai et al., 2010) . These disadvantages greatly limit the practical usage of the model. Thus, we provided two novel models incorporating matrix completion model with HA protein sequence information.
Model 3 Without Type II data
where S ij is the HA protein sequence similarity between influenza virus i and j, and X i denote the i th row of X. measures sequence similarity of virus i and j across all HA1 sites, S AD ij measures sequence similarity on 5 antigenic determinant regions (Fig. 1) , and x is a parameter to control the weight of antigenic determinants. k 1 ,k 2 and x were tuned by a 10-fold cross-validation process.
Model 4 With Type II data. Similar to Model 2,
An alternating gradient descend method
Similar to (Cai et al., 2010; Keshavan et al., 2010) , we proposed an alternating gradient descend (AGD) method to solve Model 3.
AGD algorithm 
, where U 0 and V 0 are consisted of the first r columns of U and V respectively. 3. Updating:
• Fix U k ð Þ and V k ð Þ˚a nd calculate a matrix R rÂr to minimize the square error P P ðX
• Repeat until convergence or reach a predetermined number of iterations. The gradients of U and V are Site B: 128 129 155-160 163-165 186-190 192-194 196-198 Site C: [44] [45] [46] [47] [48] 
It is of note that Keshavan et al. suggested the trimming process, which improves imputation accuracy for matrix completion from noisy entries (Keshavan et al., 2010) , and the details for computing the gradients are provided in Supplementary Information.
Model 4 could be solved exactly the same way as Model 3 by
Since HI table is not missing at random in a long time span (Cai et al., 2010) , we adopted a sliding window method to reduce temporal bias (see Fig. 2 ). Suppose the HI table spans t years, we first completed all sub-matrices from the i th year to the (i þ W-1) year
The recovered values were estimated as the mean of the values from the associated sub-matrices. In this way, we recovered W (year) orthogonal band (shaded region in Fig. 2 ) of the matrix, say X W . We then applied our model toX W to compute the finalX. The first window includes viruses and vaccines between year 1 andW, and the widow slides one year (in both virus and vaccine directions) each time until it reaches the final year. BMCSI is performed on each window and the imputed value is the average of those from corresponding windows. Finally, BMCSI is performed on the whole window with values in shaded regions being filled.
Performance evaluation
We used root-mean-square error (RMSE) to evaluate the performance of imputation algorithms. Let l ¼ l 1 ; l 2 ; . . . ; l k ð Þ and n ¼ n 1 ; n 2 ; . . . ; n k ð Þ , then the RMSE between l and n is defined as
10-fold cross-validation
We divided the observed values of Mrandomly into 10 equal parts, 9 of which were used for training and the remaining one part for prediction. The process was repeated for 10 times until each part was used as the prediction set once. The mean RMSE between the predicted values and real values across 10 runs were used to tune the model parameters k 1 ; k 2 ; x and W, and compare different algorithms.
Constructing antigenic cartography, genetic cartography and phylogenetic tree
Similar to (Barnett et al., 2012) and (Cai et al., 2010) , we defined the antigenic distance d ij between two viruses i and j to be the Euclidean distance between X i and X j . We then used multidimensional scaling (MDS) (Kruskal, 1964) to generate the coordinate of each virus based on the distances. The genetic cartography was also generated by MDS based on the uncorrected P-distances among viruses, and the phylogenetic tree was constructed by MEGA 6 using maximum likelihood method (Tamura et al., 2013).
Results
Dataset
We applied BMCSI into H3N2 influenza data which contains 3991 observed HI values from 253 viruses against 79 antisera. It is of note that there are originally 273 viruses in the Smith et al. (Smith et al., 2004) , however sequence information were not available for 20 strains. We then downloaded the HA1 protein sequences of the 253 viruses from NCBI Influenza Virus Database. According to the work of Smith et al (Smith et al., 2004) , the viruses form 11 antigenic clusters namely HK68, EN72, VI75, TX77, BK79, SI87, BE89, BE92, WU95, SY97 and FU02 respectively.
Imputing the missing values in HI table of H3N2 influenza viruses
We set the low-rank r to vary from 5 to 13, and the sliding window size W to vary from 12 to 36 with a step size of 4. A 10-fold cross validation analysis suggests a k 1 of 1 Â 10 À4 , k 2 of 1 Â 10 À9 and x of 1000 to be the best parameters. We listed the 10-fold crossvalidation RMSEs for different r and W in Table 1 . As can be seen, the lowest RMSE 0.6586 is achieved at window size 28 and rank 10. According to Cai et al. (Cai et al., 2010) , the best local RMSE value for 10-fold cross-validation is 1.0503 for smith et al. (Cai et al., 2010) using the dataset with 273 viruses. In addition, we also compared BMCSI with AntigenMap 3D (Barnett et al., 2012) , an updated version of MC-MDS, without applying sliding window. BMCSI achieved a RMSE of 1.13, better than that of AntigenMap 3D, i.e. 1.21 (Supplementary Table S1 ). The above comparisons indicate that HA1 protein sequence information is a good compensation for lowrank matrix completion. As for the two parameters, it seems that the performance of the method relies more on sliding window size than rank (Table 1 ).
In addition, to check the case in which a whole row in the HI table is missing, we artificially set one row of the H3N2 data from 1968 to 1992 (which contains 146 viruses and 1656 Type I values). We then used AntigenMap 3D and our BMCSI to recover the whole row, and calculated their predicted RMSEs. The processes were repeated for 146 times until all the rows are predicted once. We then calculated the prediction RMSE. Both methods are quite bad at prediction. However, BMCSI has an average RMSE of 5.1903, which is better than that of AntigenMap 8.2520 (S1 Data).
Antigenic cartography for H3N2 viruses
We constructed the antigenic cartography for 253 viruses in Figure  3 . As can be seen, the viruses from the later 7 clusters including BK79, SI87, BE89, BE92, WU95, SY97 and FU02 are well separated. Those from HK68, EN72, VI75 and TX77 are also generally separated but not as well as the late clusters. The small sample sizes in early years contribute at least in partial to this since our algorithm requires substantial number of observed HI values for a virus to impute other values reliably.
It can be seen from Figure 3 that the antigenic distances within and between adjacent clusters are quite different. For example, the antigenic distance between WU95 and SY97 is much larger than that between BE92 and WU95. We calculated the average withincluster and between-cluster antigenic distances for the 11 clusters ( Table 2 ). As Table 2 shows, the average within-cluster distances are less than 2 for all 11 clusters, while those between clusters are more than 2 except for pairs HK68-EN72 (1.94) and TX77-BK79 (1.80), indicating that most vaccines were updated on time. The antigenic distances between viruses become larger with the increase of time and the viruses are evolved alongside an S-shaped curve antigenically, which are consistent with previous findings (Smith et al., 2004) . 
Genetic and antigenic evolution of H3N2 influenza A viruses
To further investigate the relationship between genetic and antigenic evolution of H3N2 viruses, we constructed a maximum likelihoodbased phylogenetic tree using MEGA6 (Tamura et al., 2013) (Fig.  4a ) and a genetic map using uncorrected P-distance and MDS for the 253 viruses (Fig. 4b) . As can be seen from Figure 4b , the viruses were evolved alongside a half circle. By comparing the genetic and antigenic map, we observed an overall correspondence between them, however the shapes of the evolution are different (i.e. half circle and S-shaped). The viruses are evolved generally towards one direction genetically while switching directions antigenically. The reason might be that the viruses have to protect themselves against population immunity (Fouchier and Smith, 2010) . In addition, there are some inconsistencies between genetic and antigenic clusters. The reason might be that the new genetic clusters are formed through accumulation of mutations while only a few critical mutations are responsible for new antigenic clusters (Sun et al., 2013) .
To conduct a quantitative analysis, we calculated the mean genetic distances (uncorrected P-distance) among viruses within and between 11 antigenic clusters (Table 3 ). The distances generally increase with time, but seem not to be linear. The average withincluster genetic distances vary between 0.004 and 0.02, while those for between-cluster vary between 0.02 and 0.16. The results are generally consistent with those for antigenic distances with a Spearman correlation 0.83 (see Table 2 ). For example, the second lowest between-cluster genetic distance (i.e. 0.04) achieves between HK68 and EN72, corresponding to the second lowest between-cluster antigenic distance (i.e. 1.94) (see Table 2 ). Specifically, 4.4%61.2% genetic variance (corresponding to 3.11 6 1.08 antigenic distances) caused an antigenic drift event for H3N2 influenza viruses historically.
However, discrepancies between genetic and antigenic evolution could also be identified if we zoom into specific clusters. For example, the biggest between-cluster distance (i.e. 5.02) between adjacent antigenic clusters (i.e. BE89 and BE92) corresponds to a genetic distance of only 0.04. The phenomena suggests that not all mutations contribute to antigenic changes equivalently and thus it is critical to identify antigenic determinant regions (Lee et al., 2016) .
Evaluating the selection of vaccine strains
In the end, we proposed a simple method to optimize vaccine strains from antigenic cartography and evaluate previous vaccine strain selections. The objective is to select strains at the center of new emerging viruses.
Suppose there are n emerging viruses not protectable by previous vaccines. For each virus i, we first calculated
Then the virus with relatively low D i will be at the center of these viruses, and is a potential vaccine strain candidate. The method could be generalized to the case that the emerging viruses can be grouped into several sub-antigenic clusters, and one can infer vaccine strain candidate for each cluster for combined vaccines.
By this way, we evaluated the vaccine strains for an antigenic cluster (see Supplementary Table S2 and Fig. S1 ). As the table shows, some vaccine strains indeed rank low in their antigenic clusters. For example, SY/5/97 ranks 5th (out of 23) in antigenic cluster SY97. However, interestingly there are also a few vaccine strains not at the center of their antigenic clusters. For example, SI/2/87 ranks at 19th (out of 31) in cluster SI87. It is known that the efficacy and effectiveness of influenza vaccines are not well satisfied in a few years (Osterholm et al., 2012) . A better antigenic map is helpful to 
